[Fatal infection in patients with systemic lupus erythematosus and incidence, types, predisposing factors, and prevention--comparative study of patients with rheumatoid arthritis and primary nephrotic syndrome].
Nakabayashi
K
K
First Department of Internal Medicine, Kyorin University School of Medicine.
Arimura
Y
Y
D000328:Adult; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000276:immunology; D001424:Bacterial Infections / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control; D005260:Female; D006801:Humans; D015994:Incidence; D007564:Japan / Q000453:epidemiology; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000276:immunology; D008297:Male; D009181:Mycoses / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control; D009404:Nephrotic Syndrome / Q000150:complications* / Q000276:immunology; D011014:Pneumonia / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control; D011239:Prednisolone / Q000008:administration & dosage / Q000009:adverse effects; D018805:Sepsis / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control; D014552:Urinary Tract Infections / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control
D011239:Prednisolone